GLIOBLASTOMA is the most common and aggressive form of human brain tumor (18, 32) , its poor prognosis largely deriving from its diffuse invasiveness into normal brain parenchyma that prevents successful surgical resection. The decreased susceptibility to apoptosis displayed by migrating glioblastoma cells makes radiotherapy and chemotherapy likewise poorly effective (23, 33) . Invasiveness thus appears one of the primary challenges in contrasting these types of tumor. Despite the large body of information available on the biology of glioblastoma, the mechanisms underlying its invasiveness are still largely unknown, thus limiting the development of new drugs and specific therapeutic strategies.
The migratory behavior of glioblastoma cells could be conditioned by a number of tissue-and glioma-derived cytokines and growth factors. Among them, CHEMO-attractant cyto-KINE (chemokine) family members and their receptors have been demonstrated to play key roles in tumor progression, angiogenesis and directional migration of glioma cells (8, 10, 50) . Growing evidence shows a role for the CXC chemokine ligand 12 (CXCL12)/stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 in the migratory behavior of glioblastoma cells: CXCL12 expression in low-grade glioma has been associated with a shorter time to tumor progression (41) , whereas CXCR4 is widely expressed in glioblastoma tissues (1, 2, 60) , overexpressed in angiogenic areas and in infiltrating glioblastoma cells in vivo (10, 39, 57, 58) , and a phosphorylated/ activated form of CXCR4 is largely found in astrocytomas (54) . It has been further shown that the expression of CXCR4 in highly malignant gliomas is associated with poor prognosis (5, 31) and that CXCL12 stimulates the proliferation of glioma progenitor cells (11) . A chemotactic role of CXCL12/CXCR4 axis has been demonstrated in several glioblastoma cell lines in vitro (1, 19, 56, 59) , whereas a role in tumor progression has been proved in animal models (40) , thus confirming its potentially active role in glioblastoma invasiveness in vivo.
Despite the large body of information available on CXCL12/ CXCR4 expression and promigratory activity in glioblastoma, the underlying mechanisms are still poorly understood. CXCL12/CXCR4 interaction leads to downstream activation of several key migratory, proliferative, and survival signaling pathways, often already markedly activated in glioblastoma cells. Among them, phosphoinositide-3 kinase (PI3K) and extracellular signal-regulated kinases (ERKs) have been shown to provide key events for chemotaxis induction in a variety of cell systems (20, 35, 52) . However, other targets, such as ion channels, might be possibly involved in the modulation of glioblastoma cell migration. Specifically, the large conductance Ca 2ϩ -activated K (BK Ca ) channels and the volumeregulated Cl Ϫ channels, both largely expressed in the central nervous system (CNS), are known to underlay glioblastoma cell migration and enhance tumor progression in several experimental models (34, 46) . In addition, the intermediate conductance Ca 2ϩ -activated K (IK Ca ; K Ca 3.1) channel has been shown to play a major role in tumor cell migration: IK Ca channel inhibition decreases cell migration in a variety of cells, while its ectopic expression enhances their migratory behavior (21, 42, 44, 45) . The IK Ca channel is poorly expressed in the normal adult CNS (22) but largely expressed in glioblastomaderived human cell lines (GL15 and U251, 13). However, this is a controversial issue since, in several glioma cell lines and patient biopsies where mRNA expression of the IK Ca channel was detected, no IK Ca currents could be measured (53) .
In the present study we investigate the signaling mechanisms involved in the chemotactic action of CXCL12 on highly invasive human glioblastoma cells and compare them with those induced by epidermal growth factor (EGF), a growth factor deeply involved in glioblastoma progression (4). We found that both CXCL12 and EGF induce IK Ca channel activation but, only in case of CXCL12, IK Ca channels undergo a long-term functional upregulation and their activity is required for chemotaxis. These findings suggest the possibility that IK Ca channel mediates the in vivo promigratory capability of CXCL12 in invasive subpopulations of glioblastoma cells overexpressing CXCR4.
MATERIALS AND METHODS

Materials.
Cell culture medium (Dulbecco's modified minimum essential medium, DMEM), fetal bovine serum (FBS), penicillin G, streptomycin, glutamine, and sodium pyruvate were from GIBCO Invitrogen (Carlsbad, CA); recombinant human CXCL12 was from Peprotech (London, UK); and recombinant human EGF and Fura-2 AM were from Invitrogen (Carlsbad, CA). Antibody anti-CXCR4, Fusin (C-20) was from Santa Cruz Biotechnology (Santa Cruz, CA), anti phospho-AKT (Ser473), anti-phospho-p44/42 MAPK (Thr202/ Tyr204) E10, anti-p44/42 MAPK, and ECL were from Cell Signaling Technology (Beverly, MA); PD-98059, LY-294002, AG-1478, and BAPTA-AM were from Calbiochem (San Diego, CA); AMD-3100, tetraethylammonium (TEA), DMSO, 3-oxime-6,7-dichloro-1H-indole-2,3-dione (NS-309), secondary antibodies, and all the other chemicals were from Sigma-Aldrich (St. Louis, MO) or Pierce (Rockford, IL). Recombinant charybdotoxin (CTX) was from Alomone Labs (Jerusalem, Israel). 1-[(2-Chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) was kindly gifted by Dr. H. Wulff (University of California).
Cell cultures. Cultures of the GL15 and U251 glioblastoma multiform cell lines and the primary glioblastoma cell lines FCN and MZC (kindly provided by Dr. Antonietta Arcella, Neuromed) (6) were grown in DMEM supplemented with 10% heat-inactivated FBS, 100 IU/ml penicillin G, 100 g/ml streptomycin, 2 mM glutamine, and 1 mM sodium pyruvate. CHP 100 neuroepithelioma cells were obtained by Dr. Angelo Spinedi (Tor Vergata University, Rome, Italy). Cells were grown at 37°C in a 5% CO 2 humidified atmosphere. Medium was changed twice a week, and the cells were subcultivated when confluent.
Freshly dissociated glioblastoma cells from patients. Tumor specimens were obtained from the Neurological Science Department of Sapienza Medical School and from Neuromed, from two adult glioblastoma multiforme (GBM) patients who gave informed consent to the research proposals. The study was approved by the Institutional Ethics Committee. Tissues were processed within half an hour from surgical resection. Histopathological typing and tumor grading were done according to the WHO criteria resulting as grade IV. In detail, tumor tissues were mechanically dissociated to cell suspensions and centrifuged at 800 g for 5 min. Red blood cells were lysed with 4 vol of ammonium chloride buffer (in mM: 154 NH 4Cl, 10 KCO3, and 0.1 EDTA) at 4°C for 5 min. Tumor cells were resuspended in serum-free growth medium (DMEM with 100 IU/ml penicillin G, 100 g/ml streptomycin, 4 mM glutamine, and 1 mM sodium pyruvate) and cultured at 37°C in humidified atmosphere with 5% CO 2. Twenty-four hours later, nonadherent cells were removed and the growth medium was supplemented with 10% heat-inactivated FBS, with changes every 48 h. After about 10 days, cells were subcultured only once and then used for immunocytochemical characterization (see supplementary methods and supplementary Table 2 online at the AJP-Cell Physiol website) and chemotaxis experiments. These freshly dissociated cells are named GBM2 and GBM4 in the current study.
Indirect immunofluorescence. Glioblastoma cells were extensively washed with PBS, fixed with paraformaldehyde (PFA) 4% for 15 min, and permeabilyzed by treatment with PBS containing 0.2% Triton X-100 for 5 min. The cells were kept for 60 min at room temperature with blocking solution (PBS containing 15% BSA), then incubated overnight at 4°C with a goat anti-CXCR4, Fusin (C-20), antibody diluted 1:100 in PBS containing 3% BSA, and washed three times with PBS containing 0.1% Tween-20 and twice with PBS alone. After being treated with fluorescein isothiocyanate-conjugated rabbit antigoat IgG, diluted 1:800 in PBS containing 3% BSA, being washed three times with PBS containing 0.1% Tween-20 and twice with PBS, preparations were incubated with 2 g/ml DAPI for 5 min and dried in air. The preparations were observed using a DMRB Leika microscope.
SDS-polyacrylamide gel electrophoresis and immunoblotting. GL15 cells at one day of subculture were serum starved for 30 min in the presence or absence of PD-98059 (20 M) or LY-294002 (25 M) and then stimulated with recombinant human CXCL12 (50 nM) or with recombinant human EGF (100 ng/ml) for 15 min. Cell cultures were washed with PBS and scraped with 62.5 mM Tris·HCl (pH 6.8), 2 mM EDTA, 0.5% Triton X-100, phosphatase inhibitor cocktail II, protease inhibitor cocktail, and 2% SDS. The proteins were separated by SDS-PAGE and transferred to nitrocellulose filters. Immunolabeling of phosphorylated AKT and ERK1/2 and total-ERKs was performed following the instructions of the manufacturer. CXCR4 detection was performed on semiconfluent GL15 cells by using a goat anti-CXCR4, Fusin (C-20), antibody diluted 1:500 in TBS containing 3% nonfat dried milk, and a PO-conjugated rabbit anti-goat antibody. Enhanced chemiluminescence detection was performed using the instructions of ECL Western blotting.
Intracellular calcium measurements. Fluorescence determinations were performed by using a conventional fluorescence microscopy system composed of an upright microscope (Axioskop; Zeiss, Jena, Germany), a digital 12-bit cooled camera (SensiCam), and a monochromator (Till Photonics). The system was driven by Till Vision software (Till Photonics). Images were acquired and stored on a Dell PC, then analyzed offline. Measurements of fluorescence over time had a resolution of 0.5 Hz. GL15 cells were plated at 100,000/ml and used after 4 days of culture. Twenty-four hours before the experiment, cultures were wounded with a plastic tip, to create an empty space that allows visualization of migrating cells. Before the experiments, cells were incubated with Fura-2 AM (3 M) for 45 min and then extensively washed with external solution of the following composition (in mM): 140 NaCl, 5.6 KCl, 2 MgCl 2, 2 CaCl2, 10 glucose, and 10 HEPES-NaOH, pH 7.4. Imaging fields were chosen in the wound area. The level of intracellular free Ca 2ϩ concentration ([Ca 2ϩ ]i) was estimated, as previously described (16) , using the equation: [Ca 2ϩ ]i ϭ KD␤(R Ϫ Rmin)/(Rmax Ϫ R), where R is the ratio between the cell fluorescence images acquired at two excitation wavelengths (340 and 380 nm), Rmin ϭ 0.3, Rmax ϭ 2.3, ␤ ϭ 2.41 calculated as the ratio of Fmax and Fmin at 380 nm, KD ϭ 224 nM is the Fura-2 dissociation constant. Emission was monitored at 510 nm (optical filters and dichroic beam splitter were from Chroma, Brattleboro, VT). Drugs were applied by a gravity-driven perfusion system, with tubing connected to a final tip of 100 -200 m diameter, focally oriented onto the field of interest.
Electrophysiology. Perforated and dialyzed whole cell patch-clamp configurations were used for electrophysiological recordings from GL15 cells. Currents and voltages were amplified with a List EPC-7 amplifier (List Medical, Darmstadt, Germany), digitized with a 12 bit A/D converter (TL-1, DMA interface; Axon Instruments, Foster City, CA), and analyzed with the pClamp software package (version 7.0, Axon Instruments). For on-line data collection, macroscopic currents were filtered at 0.5 kHz (Ϫ3 dB attenuation frequency), and sampled at 200 s/point, respectively. Membrane capacitance measurements were made by using the Membrane Test routine of the pClamp software. In perforated whole cell recordings, we used an external solution containing (in mM) 106.5 NaCl, 5 KCl, 2 CaCl 2, 2 MgCl2, 5 MOPS, 20 glucose, and 30 Na-gluconate, (pH 7.25) and an internal solution containing (in mM) 57.5 K 2SO4, 55 KCl, 5 MgCl2, and 10 MOPS (pH 7.20). Electrical access to the cytoplasm was achieved by adding amphotericin B (200 M) to the pipette solution. Access resistances ranging between 15 and 25 M⍀ were achieved within 10 min from seal formation and were actively compensated to ca. 50%. In whole cell dialyzed recordings we used an external solution containing (in mM) 140 NaCl, 5 KCl, 2 CaCl 2, 2 MgCl2, 5 MOPS, and 20 glucose, (pH 7.4), and an internal solution containing (in mM) 150 KCl, 1 MgCl 2, 5 MOPS, and 1 EGTA-K (pH 7.25). The desired free Ca 2ϩ concentration [Ca 2ϩ ]i was obtained by adding varying amounts of CaCl 2 (calculated with the webmax software: www.stanford. edu/ϳcpatton/webmaxc/webmaxcS.htm) to the pipette solution. Octanol (1 mM) was added to all external solutions to block the gap junctions (12) . TRAM-34, NS309, and amphotericin B stock solutions were prepared in DMSO (20, 100, and 50 mM, respectively). The maximal DMSO concentration in the recording solutions was about 0.1%. The pharmacological agents were dissolved daily in the appropriate solution at the concentrations stated and bath applied with a superfusion system (Rapid Solution Changer RSC-200; BioLogic Science Instruments, Claix, France). The time for solution exchange was about 500 ms. Experiments were carried out at room temperature (18 -22°C). Data are presented as means Ϯ SE. Statistical differences were verified by using the t-test by considering a level of significance (P) of 0.05.
Chemotaxis assay. CXCL12-or EGF-induced chemotaxis was investigated in glioblastoma cell lines and primary cultures. Semiconfluent cells were trypsinized, preincubated in chemotaxis medium (DMEM without glutamine, 100 IU/ml penicillin G, 100 g/ml streptomycin, 0.01% BSA, and 25 mM HEPES, pH 7.4) for 15 min, and plated (500,000/well) on 10.5-mm polylysine-coated transwells (8 m pore size filters) in this same medium. When necessary, cells were preincubated 15 min with LY-294002 (25 M), PD98059 (20 M), AMD-3100 (1 g/ml), AG-1478 (250 nM), TRAM-34 (2.5, 5, or 10 M), CTX (100 nM), BAPTA-AM (10 or 20 M), or TEA (1 mM), which were also present during the assay. In all the experiments the final concentration of DMSO was 0.1%. The lower chambers contained chemotaxis medium enriched with CXCL12 (50 nM), EGF (100 ng/ml), or vehicle. After 3 h of incubation at 37°C, cells were treated with ice-cold 10% trichloroacetic acid for 10 min. Cells adhering to the upper side of the filter were scraped off, whereas cells on the lower side were stained with a solution containing 50% isopropanol, 1% formic acid, and 0.5% (wt/vol) brilliant blue R 250. Stained cells were counted in more than 20 fields with a ϫ40 objective. For chemotaxis experiments of freshly dissociated glioblastoma tissues (GBM) and short hairpin RNA (shRNA)-green fluorescent protein (GFP)-transfected GL15 cells, trypsinized cells were plated (30,000 -80,000/well) on polylysine-coated FluoroBlok 24-multiwell inserts (8-m pore size filters, BD Biosciences). For GL15 cells, the lower chambers contained CXCL12 (50 nM), EGF (100 ng/ml), or vehicle. For GBM, the lower chambers contained CXCL12 (50 nM), TRAM-34 (5 M, preincubated for 15 min), both, or vehicle. After 4 h of incubation at 37°C, cells were fixed with 4% PFA. Migrated GBMs were stained with Hoechst. Migrated, GFPpositive GL15 and GBM cells were counted in 10 fields with a ϫ40 objective.
shRNA transfection. shRNA that targets the nucleotide sequence of the human IKCa channel (KCCN4, NM_002250) and shRNA-negative controls were purchased from SA Biosciences. The shRNAs, inserted in the pGeneClip hMGFP Vector, express the shRNA under the control of the U1 promoter and the GFP gene. GL15 cells were transfected with Lipofectamine 2000 (Invitrogen) and used after 48 h, when the percentage of transfected cells was 27% Ϯ 3%.
RESULTS
GL15 cells express CXCR4 and respond to CXCL12 in the transwell chemotactic assay. CXCR4 is widely expressed in human glioblastoma cell lines, although its expression profile can be highly heterogeneous both among different cell lines and, within the same cell line, among different cell subpopulations (56) . We analyzed the expression pattern of CXCR4 in the human glioblastoma cell line GL15, which has been demonstrated to be tumorigenic and endowed with invasive properties in in vivo experimental models (17, 38) . Immunofluorescence analysis indicates a mosaic expression of CXCR4 in the heterogeneous GL15 population (Fig. 1A) , confirmed by Western blot analysis where a single band of 37 kDa is detected (Fig. 1B) . The same immunoreactivity was detected in U251 glioblastoma, in CHP-100 (neuroepithelioma), and HeLa cells (Fig. 1B) , where CXCR4 expression was previously demonstrated (7, 14) . To analyze GL15 response to CXCR4 activation, we performed the transwell chemotactic assay and demonstrated that these cells indeed migrate toward CXCL12 in a dose-dependent way (Fig. 1C) . A specific CXCR4 antagonist AMD-3100 (1 g/ml) completely abolished CXCL12-induced cell movement, thus indicating a specific involvement of CXCR4 (Fig. 1D) . We then compared the effect of CXCL12 on glioblastoma cell migration with that of EGF, whose receptor is overexpressed on these same cells (51) . The results, reported in Fig. 1E , show similar chemotactic indexes between CXCL12 and EGF and a specific block of EGF effect by AG-1478 (250 nM).
Role of ERK and PI3K pathways on CXCL12-induced GL15 cell migration. It has been demonstrated that the chemotactic activity of CXCL12 can be mediated by different signal transduction pathways in different cellular systems (14, 36, 37) . We focused on the involvement of the ERK and PI3K pathways, since the basal activity of these kinases is reported to be already high in glioblastomas (3, 55) . We first analyzed the effect of CXCL12 on ERK1/2 and protein kinase B (AKT) phosphorylation and report that only ERK1/2 was significantly phosphorylated upon cell stimulation, whereas pAKT levels were unaltered (Fig. 2A) ; in the presence of the MEK activation inhibitor PD-98059 (20 M, 30 min pretreatment), CXCL12-induced ERK1/2 phosphorylation was completely blocked ( Fig. 2A) , as expected. When the chemotactic assay was performed in the presence of PD-98059, a partial reduction of CXCL12-induced chemotactic activity was observed (Fig.  2B) , suggesting a minor involvement of ERK1/2 pathway in CXCL12-induced chemotaxis of GL15 cells. On the other hand, in accordance with data on AKT phosphorylation, when chemotactic assay was performed in the presence of LY-294002, no reduction of CXCL12-induced cell migration was observed (Fig. 2B) , and the same result was obtained with a different glioblastoma cell line U251 (Fig. 2B, inset) . However, since the PI3K-AKT pathway is known to play pivotal roles in the migratory behavior of glioblastoma cells (25, 27) , we decided to investigate whether the lack of involvement of PI3K-AKT pathway in CXCL12-induced cell migration was a general feature of these cells. For this reason, we performed chemotactic assay on GL15 cells toward EGF in the presence of LY-294002 or PD-98059. The results obtained demonstrate that EGF (100 ng/ml, 15 min) induces significant AKT and ERK1/2 phosphorylation in GL15 cells (Fig. 2C) and its chemotactic activity is efficiently abrogated by both LY-294002 and PD-98059 treatment (Fig. 2D) . From these results we conclude that the ERK pathway is involved in both EGF and CXCL12-induced cell migration, and the PI3K-AKT activity is a key effector of EGF-directed cell migration, whereas it constituted a dispensable signal for CXCL12-induced chemotaxis of GL15 cells. mobilization, we performed measurements of Ca 2ϩ mobilization on Fura-2 AM-loaded GL15 cells actively migrating into a wounded area (see MATERIALS AND METHODS). In these cells, the application of CXCL12 (50 nM) induced a clear increase of intracellular Ca 2ϩ levels (Fig. 3A) . Responsive cells (n ϭ 135/523; 28 fields; 12 cultures) showed some variability as concern the kinetics of Ca 2ϩ transients (not shown), which slowly recovered to control upon chemokine washout and could be observed upon repeated chemokine application. GL15 cells were significantly more responsive to EGF (100 ng/ml; n ϭ 167/393; 22 fields; 11 cultures) than to CXCL12, as judged from the higher proportion of responsive cells. The Ca 2ϩ concentration which, in basal conditions, was 75 Ϯ 7 nM (n ϭ 112), increased upon CXCL12 and EGF application, respectively, to 554 Ϯ 64 nM (n ϭ 83/106, 6 fields, 3 cultures) and 686 Ϯ 120 nM (n ϭ 81/81, 4 fields, 2 cultures; Fig. 3A) .
CXCL12 induces transient increase of intracellular
To assess whether Ca 2ϩ mobilization plays a functional role in the chemotactic response of GL15 cells to CXCL12, we performed transwell chemotactic assays in the presence of BAPTA-AM (10 M), an intracellular Ca 2ϩ chelator. The chemotactic response to CXCL12 was completely inhibited by the presence of BAPTA-AM (Fig. 3B) , whereas basal level of cell migration was not affected (not shown). Similar results were obtained with U251 cells (Fig. 3B, inset) , suggesting common mechanisms in different glioblastoma cell lines. In contrast, as shown in Fig. 3C , EGF-induced migration of GL15 cells was completely independent of intracellular Ca 2ϩ thus indicating that the same cells respond to different chemotactic stimuli with distinct transduction programs. To discard the hypothesis that our experimental conditions (15-min preincubation with BAPTA-AM 10 M, also present during all the chemotactic assays) were not sufficient to prevent EGF-induced intracellular Ca 2ϩ transients, two control experiments were performed: 1) chemotactic assay was performed either with higher BAPTA-AM concentrations (20 M) or with longer preincubation time (1 h). Under both conditions, EGF was still fully able to induce GL15 cell chemotaxis (data not shown). 2) Ca 2ϩ measurements upon CXCL12 and EGF treatment were performed in cells loaded with both Fura-2 AM (1-4 M) and BAPTA-AM (10 -20 M). These experiments showed that in the presence of BAPTA-AM, both EGF-or CXCL12-induced Ca 2ϩ transients were almost abolished, being reduced in amplitude by 10-to 20-folds with respect to control (not shown). Both results strongly support the observation that, in glioblastoma, EGF-induced cell migration is largely Ca 2ϩ independent. Activation of IK Ca channels is involved in CXCL12-induced glioblastoma cell migration. The CXCL12-induced Ca 2ϩ increase in actively migrating GL15 cells could activate several Ca 2ϩ -dependent channels, including BK Ca and IK Ca shown to be involved in the migration of several cell types, including tumor cells (45, 53) . By using the scratch wounding experimental model and the perforated whole cell configuration of the patch clamp to maintain the integrity of intracellular transduction systems, we investigated whether the Ca 2ϩ -activated K ϩ currents were activated by the acute administration of CXCL12. After application of CXCL12 (50 nM, 15-40 s) and ramp protocols from Ϫ100 to ϩ100 mV, repeated every 5 s, a large (and comparable) percentage of cells both within (16/34) and outside the wounded area (5/11) showed the activation of a voltage independent outward current ( Fig. 4A ) displaying a reversal potential close to the equilibrium potential of K ϩ ions (E K about Ϫ90 mV, Fig. 4A, inset) . The responsive cells within the wounded area displayed, however, a CXCL12-induced K ϩ current density (5.7 Ϯ 1.3 pA/pF, n ϭ 17) much higher than cells outside the wounded area (1.6 Ϯ 0.4 pA/pF, n ϭ 5; Fig. 4B ).
To establish the molecular nature of the channel sustaining the CXCL12-induced K ϩ current, we made short applications of CXCL12 in the continuous presence of either TRAM-34 or TEA, selective inhibitors of IK Ca and BK Ca channels, respectively. Preliminary analysis of K Ca channel expression on these cells showed that all three BK Ca , IK Ca , and SK Ca (1, 2, 3) channels are expressed (Supplementary Fig. 1 ). Preincubation with TRAM-34 (2.5 M) completely prevented the CXCL12-induced K ϩ current activation, whereas no significant effect was found when cells were preincubated with TEA (3 mM), indicating the main contribution of IK Ca channels in this response (Fig. 4, C and D) . Another inhibitor of IK Ca , CTX (100 nM), also efficiently prevented the induction of CXCL12-induced K ϩ current activation (data not shown). By using the same experimental protocol, we also tested the effectiveness of EGF in activating the IK Ca channel. As shown in Fig. 4 , E and F, EGF (100 ng/ml, applied for 15-90 s) was able to activate, in a fraction of GL15 cells within wounding (3/9), a current that had very similar features as the current activated by CXCL12. Only the E rev was slightly more depolarized (5-10 mV) when compared with CXCL12-induced current (Fig. 4F) , indicating the modulation of other currents.
We then investigated the modulations of IK Ca channels following longer CXCL12 and EGF treatments (90 min) to better compare the electrophysiological data with those obtained in the chemotaxis experiments. To this purpose, we indirectly evaluated the level of IK Ca channel expression by using the dialyzed whole cell configuration (with 1 M Ca 2ϩ in the pipette solution) and activating the IK Ca channel with its selective agonist NS-309. After seal breaking was completed, we usually observed the development of an outward current with reversal potential close to E K . Once the current had stabilized (which required 4 -7 min), application of NS-309 further increased the K ϩ current, which was completely inhibited by TRAM-34 application, indicating that the current was indeed completely sustained by the IK Ca channel (Fig. 5A) . In Fig. 5B we show IK Ca current densities measured at 0 mV from ramp records, in control cells, and in cells subjected to 90 min treatment with either CXCL12 or EGF. Statistical analysis indicates a significant increase of IK Ca current densities after 90 min treatment with CXCL12 (C: 14.6 Ϯ 2.8 pA/pF, n ϭ 26; CXCL12: 27.2 Ϯ 2.6 pA/pF, n ϭ 20; P Ͻ 0.05). This result is likely indicative of an increased channel expression that was, however, not detected by RT-PCR analysis, suggesting a post- trascriptional regulatory mechanism (Supplementary Fig. 2 ). By contrast, treatment with EGF for 90 min did not increase the IK Ca -evoked current significantly (EGF: 18.3 Ϯ 4.2 pA/pF, n ϭ 10; P Ͼ 0.05).
Since the ERK1/2 activity is involved in the functional expression of IK Ca channels in GL15 cells (13) , as well as in the chemotactic activity of CXCL12 (this study), we tested whether ERK1/2 was also involved in the CXCL12-induced upregulation of IK Ca channels. Our results show that PD-98059, which specifically inhibits ERK activation, is unable to inhibit the IK Ca currents upregulation induced by CXCL12 (Fig. 5C) .
Our results thus point to IK Ca channels as main target of both short-and long-term effects of CXCL12 on GL15 cells. To investigate whether IK Ca channels were key effectors for the chemotactic activity of CXCL12, transwell chemotaxis assays were performed in the presence of TRAM-34, TEA, or CTX. Results, shown in Fig. 6A , indicate that TRAM-34 (both at 2.5 and 5 M) completely inhibited CXCL12-induced cell migration without interfering with basal migration (data not shown). In contrast, TEA (1 mM) was unable to affect CXCL12-induced GL15 cell migration, demonstrating that BK Ca channels are not involved in this process. CTX (100 nM) also efficiently abolished CXCL12-induced GL15 cell migration (Fig. 6A) . This observation led us to rule out the involvement of nonselective cation channels (shown to be TRAM-34 sensitive but CTX insensitive, 43) in CXCL12-induced cell migration. TRAM-34 also inhibits CXCL12-induced chemotaxis in other human glioblastoma cell lines: U251, where the Fig. 3 . CXCL12-induced glioblastoma cell migration requires Ca 2ϩ . A: transient increase in intracellular Ca 2ϩ concentration in a Fura-2-loaded GL15 cell, superfused with external medium containing CXCL12 (50 nM) or EGF (100 ng/ml), as indicated. B: effects of BAPTA-AM (10 M, 15 min preincubation) on CXCL12-induced GL15 and U251 (inset) cell migration. C: effect of BAPTA-AM on EGF-induced GL15 cell migration. For B and C data are reported as in Fig. 1 and are means Ϯ SE of at least three independent experiments. Statistical significance is *P Ͻ 0.05; **P Ͻ 0.01, Student's t-test. . D: mean current densities evoked by CXCL12 at 0 mV of applied potential, in control conditions and in presence of either 3 mM TEA or 2.5 M TRAM-34. Data are normalized to the mean current density evoked in control conditions. E: time course of IKCa current activation by EGF (100 ng/ml), measured at 0 mV from ramp voltage protocols from Ϫ100 to ϩ100 mV, applied every 5 s from a V holding of 0 mV, and obtained from a cell within wounded area. F: representative ramp current traces from Ϫ100 to ϩ100 mV from a V holding of 0 mV, corresponding to the time points 1, 2, and 3 shown in E. Inset: bar plot of mean IKCa current density induced by EGF, estimated as described above, from the three responsive cells within wound area. Statistical significance is **P Ͻ 0.01, Student's t-test.
functional expression of IK Ca channels was previously demonstrated (13), FCN, and MZC (Table 1) . Furthermore, when the effect of TRAM-34 was tested on two different freshly dissociated glioblastoma tissues from patients, the chemotactic response to CXCL12 was completely abolished (Table 1) . By contrast, EGF-induced GL15 cell migration was affected neither by TRAM-34 (5 M), CTX (100 nM), nor TEA (1 mM) treatment (Fig. 6B) , indicating that migration induced by different agonists can be achieved through distinct executor programs.
IK Ca channels silencing by shRNA selectively abolished CXCL12-induced glioblastoma cell migration. To further corroborate the specific involvement of IK Ca channels in CXCL12-induced glioblastoma cell migration, GL15 cells were transfected with plasmids containing shRNA-GFP specific for IK Ca channels or control GFP vector. Forty-eight hours after transfection, GFPlabeled cells (which account for about 30% of total cells) were analyzed for efficacy of IK Ca channel silencing upon 5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one (DCEBIO) or NS3009 treatment. Figure 7A shows representative DCEBIO (100 M)-activated membrane currents recorded with a ramp voltage protocol from Ϫ100 to ϩ100 mV (V h ϭ 0 mV) in GL15 cells transfected with control shRNA (C) or with the specific IK Ca shRNA. The IK Ca current density was markedly smaller in cells transfected with IK Ca shRNAs than in control cells ( Fig. 7B ; C: 20.7 Ϯ 3.1 pA/pF, n ϭ 20; IK Ca shRNA: 2.1 Ϯ 0.4 pA/pF, n ϭ 23; P ϭ Ͻ0.01), demonstrating the efficacy of silencing. IK Ca shRNA-transfected cells were also tested in a chemotaxis assay in response to CXCL12 and EGF. Results, shown in Fig. 7C , show that IK Ca channels silencing efficiently and selectively abolished CXCL12-induced chemotaxis, with no significant effect on EGFinduced cell migration.
DISCUSSION
Chemokines have long been known to be involved in promoting tumor growth, modulating angiogenesis, proliferation, and tissue invasion. In particular, CXCR4 is the most common chemokine receptor expressed in cancer cells (61) . Several studies have shown that CXCR4 and CXCL12 are both expressed in glioblastoma cells (10) . In vitro, CXCL12 has growth-promoting, survival, and chemotactic effects on glioblastoma cells (11) and, in vivo, AMD-3100 reduces the growth of glioblastoma xenografts (40) . The constitutive expression of CXCL12 and of its two receptors CXCR4 and Fig. 1 and are means Ϯ SE of at least three independent experiments. Statistical significance is *P Ͻ 0.05; **P Ͻ 0.01; Student's t-test.
CXCR7 on brain endothelial cells in normal and tumor parenchyma (29, 30) and the correlation between a shorter time to tumor progression and CXCL12 expression (41) suggest a role for CXCL12 in glioblastoma pathogenesis. Ion channels may also be deeply involved in glioblastoma pathogenesis. To infiltrate the narrow extracellular spaces of the brain, tumor cells require to promptly regulate cell shape and volume. The cell shape changes can be achieved by the coordinated local extrusion of Cl Ϫ , K ϩ , and water (48) . Activity of different ion channels has been correlated with glioblastoma cell migration: the opening of BK Ca channels inhibits glioma cell migration (26) , so does the inhibition of Cl Ϫ channels (34, 47) . Furthermore, glioblastoma cell migration can be modulated by a constitutively active voltage-independent Na ϩ current whose activity, in normal astrocytes, is regulated by the acid-sensing ion channel ASIC2, which is not present on the plasma membrane of glioblastoma cells (49) .
The role of IK Ca channels in tumor and nontumor cell migration has been reported (21, 42, 44) . The involvement of IK Ca channel in bradykinin-induced microglial cell migration has been explained by the reverse-mode operation of Na ϩ / Ca 2ϩ exchanger, which provides a Ca 2ϩ influx responsible for IK Ca activation (21) . In transformed renal epithelial (MadinDarby canine kidney, MDCK-F) cells, fibroblast growth factor-2 induces an increased rate of migration in a IK Ca -dependent way (24) . In contrast, in endothelial cells, CXCL12-mediated migration requires the activity of BK Ca channels (28) which, on the other hand, is not required for LPA-induced microglial cell migration (42) . In this paper we demonstrate the specific involvement of IK Ca channel activity in CXCL12-induced glioblastoma cell migration showing that CXCL12 activates the IK Ca current and its blockage inhibits cell migration. By contrast we show that BK Ca channels are apparently not involved, since they are not activated by CXCL12 and cell migration is not inhibited by TEA treatment.
In addition, we provide evidence that the activation of the IK Ca channel is not a general requirement for glioblastoma chemotaxis, since the chemotactic action of EGF, a growth factor whose roles in glioblastoma cell migration is well described (4), does not require IK Ca channel activity in GL15 cells. Consistently, in the same cell line we show that while intracellular Ca 2ϩ is necessary for CXCL12-induced glioblastoma cell migration, it is not required for the chemotactic activity of EGF. These data could be explained with a basal sustained activity of signaling pathways, which render unnecessary the Ca 2ϩ transients upon activation of EGFR, overexpressed by these cells (50) . Alternatively, since it has been suggested that only IK Ca channels positioned at the rear edge of migrating cells play an active role in modulating cell migration (45) , the specific subcellular colocalization of IK Ca with CXCR4 or EGFR could account for these differences. In addition, we demonstrated that CXCL12 treatment of actively migrating glioblastoma cells, selected in a wounded region of the culture dish, increases the IK Ca current density not due to increased transcription but possibly reflecting a posttranslational modification and/or increased membrane expression. Again these results are specific for CXCL12 treatment since EGF did not induce a similar upregulation of IK Ca currents within the time frame of the chemotactic assay. Values are means Ϯ SE and are expressed as percent of stimulated versus unstimulated samples. n ϭ 3-6; *P Ͻ 0.05, †P Ͻ 0.01 vs. control. Furthermore, we describe that CXCL12-induced glioblastoma cell migration is independent of the activity of the PI3K pathway, in two different glioblastoma cell lines, while EGFinduced cell migration requires PI3K activation. A similar PI3K-independent migration of glioma cells is reported for vitronectin (9) ; however, different results on PI3K dependency are reported for CXCL12-induced cell migration on different cell lines, likely reflecting coupling of the migratory machine to different signaling components in different cell types (14, 15) . Moreover, we could hypothesize that a different subcellular localization of EGF and CXCR4 receptors in glioblastoma cells could evoke the selective activation of PI3K and IK Ca channels present on different regions of migrating cells (e.g., at the rear or front edge), playing or not a role in cell migration.
In conclusion, in this paper we report that CXCL12 and EGF, both agents deeply involved in glioblastoma cell biology and tumor progression, modulate directional cell migration with different mechanisms. EGF-induced chemotaxis largely relies on the ERK1/2 and PI3K pathways, whereas CXCL12-induced chemotaxis mainly requires Ca 2ϩ transients and IK Ca activity and involves the upregulation of IK Ca current density in responsive cells. These findings might introduce a novel therapeutic approach to contrast glioblastoma spreading in healthy parenchyma based on the modulation of the signaling mechanisms downstream of CXCR4 activation.
